<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36969253</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1095830</StartPage><MedlinePgn>1095830</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1095830</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1095830</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a severe autoimmune disease that displays considerable heterogeneity not only in its symptoms, but also in its environmental and genetic causes. Studies in SLE patients have revealed that many genetic variants contribute to disease development. However, often its etiology remains unknown. Existing efforts to determine this etiology have focused on SLE in mouse models revealing not only that mutations in specific genes lead to SLE development, but also that epistatic effects of several gene mutations significantly amplify disease manifestation. Genome-wide association studies for SLE have identified loci involved in the two biological processes of immune complex clearance and lymphocyte signaling. Deficiency in an inhibitory receptor expressed on B lymphocytes, Siglec-G, has been shown to trigger SLE development in aging mice, as have mutations in DNA degrading DNase1 and DNase1l3, that are involved in clearance of DNA-containing immune complexes. Here, we analyze the development of SLE-like symptoms in mice deficient in either <i>Siglecg</i> and <i>DNase1</i> or <i>Siglecg</i> and <i>DNase1l3</i> to evaluate potential epistatic effects of these genes. We found that germinal center B cells and follicular helper T cells were increased in aging <i>Siglecg</i> <sup>-/-</sup> x <i>Dnase1</i> <sup>-/-</sup> mice. In contrast, anti-dsDNA antibodies and anti-nuclear antibodies were strongly increased in aging <i>Siglecg<sup>-/-</sup></i> x <i>Dnase1l3<sup>-/-</sup></i> mice, when compared to single-deficient mice. Histological analysis of the kidneys revealed glomerulonephritis in both <i>Siglecg</i> <sup>-/-</sup> x <i>Dnase1</i> <sup>-/-</sup> and <i>Siglecg<sup>-/-</sup></i> x <i>Dnase1l3<sup>-/-</sup></i> mice, but with a stronger glomerular damage in the latter. Collectively, these findings underscore the impact of the epistatic effects of <i>Siglecg</i> with <i>DNase1</i> and <i>Dnase1l3</i> on disease manifestation and highlight the potential combinatory effects of other gene mutations in SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Korn, Steffensen, Brandl, Royzman, Daniel, Winkler and Nitschke.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Korn</LastName><ForeName>Marina A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Biology, University of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steffensen</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Biology, University of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandl</LastName><ForeName>Carolin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Biology, University of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royzman</LastName><ForeName>Dmytro</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Biology, University of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immune Modulation, University Hospital of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephropathology, University Hospital of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Biology, University of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitschke</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Biology, University of Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="C114484">Dnase1l3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004706">Endodeoxyribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C522403">Siglecg protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.21.1</RegistryNumber><NameOfSubstance UI="D003850">Deoxyribonuclease I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D063265">Sialic Acid Binding Immunoglobulin-like Lectins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004706" MajorTopicYN="Y">Endodeoxyribonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="Y">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003850" MajorTopicYN="Y">Deoxyribonuclease I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063265" MajorTopicYN="Y">Sialic Acid Binding Immunoglobulin-like Lectins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cell signaling</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">inhibitory receptors</Keyword><Keyword MajorTopicYN="N">lymphocytes</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor EH declared a past co-authorship with the authors CB and LN.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>27</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36969253</ArticleId><ArticleId IdType="pmc">PMC10030676</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1095830</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update on the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis (2021) 80:14&#x2013;25. doi:&#xa0;10.1136/annrheumdis-2020-218272</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218272</ArticleId><ArticleId IdType="pubmed">33051219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulos D, Kostopoulou M, Pieta A, Karageorgas T, Tseronis D, Chavatza K, et al. . Evolving phenotype of systemic lupus erythematosus in caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the &#x2018;Attikon&#x2019; cohort. Lupus (2020) 29:514&#x2013;22. doi:&#xa0;10.1177/0961203320908932</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320908932</ArticleId><ArticleId IdType="pmc">PMC7168806</ArticleId><ArticleId IdType="pubmed">32106788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulff-M&#xf8;ller CJ, Svendsen AJ, Viemose LN, Jacobsen S. Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort. Semin Arthritis Rheum (2018) 47:538&#x2013;44. doi:&#xa0;10.1016/j.semarthrit.2017.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2017.06.007</ArticleId><ArticleId IdType="pubmed">28755788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C-F, Grainge MJ, Valdes AM, See L-C, Luo S-F, Yu K-H, et al. . Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern Med (2015) 175:1518&#x2013;26. doi:&#xa0;10.1001/jamainternmed.2015.3528</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.3528</ArticleId><ArticleId IdType="pubmed">26193127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo MS. Monogenic lupus. Curr Rheumatol Rep (2016) 18:71. doi:&#xa0;10.1007/s11926-016-0621-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-016-0621-9</ArticleId><ArticleId IdType="pubmed">27812953</ArticleId></ArticleIdList></Reference><Reference><Citation>Relle M, Schwarting A. Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus. Clin Dev Immunol (2012) 2012:584374. doi:&#xa0;10.1155/2012/584374</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/584374</ArticleId><ArticleId IdType="pmc">PMC3385965</ArticleId><ArticleId IdType="pubmed">22761632</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EE, Edberg JC, Kimberly RP. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity (2007) 40:567&#x2013;81. doi:&#xa0;10.1080/08916930701763710</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930701763710</ArticleId><ArticleId IdType="pubmed">18075791</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley IT, Kaufman KM, Langefeld CD, Harley JB, Kelly JA. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet (2009) 10:285&#x2013;90. doi:&#xa0;10.1038/nrg2571</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2571</ArticleId><ArticleId IdType="pmc">PMC2737697</ArticleId><ArticleId IdType="pubmed">19337289</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang SH, Athanasopoulos V, Ellyard JI, Chuah A, Cappello J, Cook A, et al. . Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus. Nat Commun (2019) 10:2201. doi:&#xa0;10.1038/s41467-019-10242-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10242-9</ArticleId><ArticleId IdType="pmc">PMC6525203</ArticleId><ArticleId IdType="pubmed">31101814</ArticleId></ArticleIdList></Reference><Reference><Citation>Dema B, Charles N. Autoantibodies in SLE: Specificities, isotypes and receptors. Antibodies (Basel) (2016) 5. doi:&#xa0;10.3390/antib5010002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antib5010002</ArticleId><ArticleId IdType="pmc">PMC6698872</ArticleId><ArticleId IdType="pubmed">31557984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 6:280&#x2013;9. doi:&#xa0;10.1038/nrrheum.2010.46</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2010.46</ArticleId><ArticleId IdType="pubmed">20431553</ArticleId></ArticleIdList></Reference><Reference><Citation>Toong C, Adelstein S, Phan TG. Clearing the complexity: Immune complexes and their treatment in lupus nephritis. Int J Nephrol Renovasc Dis (2011) 4:17&#x2013;28. doi:&#xa0;10.2147/IJNRD.S10233</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJNRD.S10233</ArticleId><ArticleId IdType="pmc">PMC3108794</ArticleId><ArticleId IdType="pubmed">21694945</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard ML, Gilkeson G. Mouse models of lupus: What they tell us and what they don&#x2019;t. Lupus Sci Med (2018) 5. doi:&#xa0;10.1136/lupus-2016-000199</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000199</ArticleId><ArticleId IdType="pmc">PMC5786947</ArticleId><ArticleId IdType="pubmed">29387435</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyel PA. Dnases in health and disease. Dev Biol (2017) 429:1&#x2013;11. doi:&#xa0;10.1016/j.ydbio.2017.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2017.06.028</ArticleId><ArticleId IdType="pubmed">28666955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisirak V, Sally B, D&#x2019;Agati V, Martinez-Ortiz W, &#xd6;z&#xe7;akar ZB, David J, et al. . Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell (2016) 166:88&#x2013;101. doi:&#xa0;10.1016/j.cell.2016.05.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.034</ArticleId><ArticleId IdType="pmc">PMC5030815</ArticleId><ArticleId IdType="pubmed">27293190</ArticleId></ArticleIdList></Reference><Reference><Citation>Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, M&#xf6;r&#xf6;y T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet (2000) 25:177&#x2013;81. doi:&#xa0;10.1038/76032</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/76032</ArticleId><ArticleId IdType="pubmed">10835632</ArticleId></ArticleIdList></Reference><Reference><Citation>Napirei M, Ricken A, Eulitz D, Knoop H, Mannherz HG. Expression pattern of the deoxyribonuclease 1 gene: Lessons from the Dnase1 knockout mouse. Biochem J (2004) 380:929&#x2013;37. doi:&#xa0;10.1042/BJ20040046</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20040046</ArticleId><ArticleId IdType="pmc">PMC1224217</ArticleId><ArticleId IdType="pubmed">15015938</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, et al. . Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet (2001) 28:313&#x2013;4. doi:&#xa0;10.1038/91070</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/91070</ArticleId><ArticleId IdType="pubmed">11479590</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaint J, Herter JM, van Aken H, Napirei M, D&#xf6;ring Y, Weber C, et al. . Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap&#x2013;mediated sterile inflammation. Blood (2014) 123:2573&#x2013;84. doi:&#xa0;10.1182/blood-2013-07-516484</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-07-516484</ArticleId><ArticleId IdType="pubmed">24335230</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Sun X, Xu J, Gu Y, Liu S, Xu S, et al. . Association study of TRAP1 gene polymorphisms with susceptibility and glucocorticoids efficacy of systemic lupus erythematosus. Gene (2018) 671:117&#x2013;26. doi:&#xa0;10.1016/j.gene.2018.05.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.05.109</ArticleId><ArticleId IdType="pubmed">29859285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny EF, Raupach B, Abu Abed U, Brinkmann V, Zychlinsky A. Dnase1 -deficient mice spontaneously develop a systemic lupus erythematosus-like disease. Eur J Immunol (2019) 49:590&#x2013;9. doi:&#xa0;10.1002/eji.201847875</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201847875</ArticleId><ArticleId IdType="pubmed">30758851</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisenburger T, von Neubeck B, Schneider A, Ebert N, Schreyer D, Acs A, et al. . Epistatic interactions between mutations of deoxyribonuclease 1-like 3 and the inhibitory fc gamma receptor IIB result in very early and massive autoantibodies against double-stranded DNA. Front Immunol (2018) 9:1551. doi:&#xa0;10.3389/fimmu.2018.01551</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01551</ArticleId><ArticleId IdType="pmc">PMC6041390</ArticleId><ArticleId IdType="pubmed">30026744</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mayouf SM, Sunker A, Abdwani R, Abrawi SA, Almurshedi F, Alhashmi N, et al. . Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet (2011) 43:1186&#x2013;8. doi:&#xa0;10.1038/ng.975</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.975</ArticleId><ArticleId IdType="pubmed">22019780</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellusova J, D&#xfc;ber S, G&#xfc;ckel E, Binder CJ, Weiss S, Voll R, et al. . Siglec-G regulates B1 cell survival and selection. J Immunol (2010) 185:3277&#x2013;84. doi:&#xa0;10.4049/jimmunol.1001792</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1001792</ArticleId><ArticleId IdType="pubmed">20729333</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller J, Nitschke L. The role of CD22 and siglec-G in b-cell tolerance and autoimmune disease. Nat Rev Rheumatol (2014) 10:422&#x2013;8. doi:&#xa0;10.1038/nrrheum.2014.54</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2014.54</ArticleId><ArticleId IdType="pubmed">24763061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc&#x3b3;RIIB-deficient mice results from strain-specific epistasis. Immunity (2000) 13:277&#x2013;85. doi:&#xa0;10.1016/s1074-7613(00)00027-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1074-7613(00)00027-3</ArticleId><ArticleId IdType="pubmed">10981970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, et al. . Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell (1995) 83:301&#x2013;11. doi:&#xa0;10.1016/0092-8674(95)90171-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90171-x</ArticleId><ArticleId IdType="pubmed">7585947</ArticleId></ArticleIdList></Reference><Reference><Citation>Pao LI, Lam K-P, Henderson JM, Kutok JL, Alimzhanov M, Nitschke L, et al. . B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes b-1a cell development and causes systemic autoimmunity. Immunity (2007) 27:35&#x2013;48. doi:&#xa0;10.1016/j.immuni.2007.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.04.016</ArticleId><ArticleId IdType="pubmed">17600736</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe4;ubli H, Varki A. Sialic acid&#x2013;binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses. Cell Mol Life Sci (2020) 77:593&#x2013;605. doi:&#xa0;10.1007/s00018-019-03288-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03288-x</ArticleId><ArticleId IdType="pmc">PMC7942692</ArticleId><ArticleId IdType="pubmed">31485715</ArticleId></ArticleIdList></Reference><Reference><Citation>Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7:255&#x2013;66. doi:&#xa0;10.1038/nri2056</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2056</ArticleId><ArticleId IdType="pubmed">17380156</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller J, Lunz B, Schwab I, Acs A, Nimmerjahn F, Daniel C, et al. . Siglec-G deficiency leads to autoimmunity in aging C57BL/6 mice. J Immunol (2015) 195:51&#x2013;60. doi:&#xa0;10.4049/jimmunol.1403139</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1403139</ArticleId><ArticleId IdType="pubmed">25987743</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;kers S, Urbat A, Daniel C, Amann K, Smith KG, Esp&#xe9;li M, et al. . Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice. J Immunol (2014) 192:2994&#x2013;3002. doi:&#xa0;10.4049/jimmunol.1303367</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303367</ArticleId><ArticleId IdType="pubmed">24600033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Molineros JE, Looger LL, Zhou X-J, Kim K, Okada Y, et al. . High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat Genet (2016) 48:323&#x2013;30. doi:&#xa0;10.1038/ng.3496</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3496</ArticleId><ArticleId IdType="pmc">PMC4767573</ArticleId><ArticleId IdType="pubmed">26808113</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores R, Zhang P, Wu W, Wang X, Ye P, Zheng P, et al. . Siglec genes confer resistance to systemic lupus erythematosus in humans and mice. Cell Mol Immunol (2018) 16:154&#x2013;64. doi:&#xa0;10.1038/cmi.2017.160</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.160</ArticleId><ArticleId IdType="pmc">PMC6355849</ArticleId><ArticleId IdType="pubmed">29503442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann A, Kerr S, Jellusova J, Zhang J, Weisel F, Wellmann U, et al. . Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol (2007) 8:695&#x2013;704. doi:&#xa0;10.1038/ni1480</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1480</ArticleId><ArticleId IdType="pubmed">17572677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettitt SJ, Liang Q, Rairdan XY, Moran JL, Prosser HM, Beier DR, et al. . Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat Methods (2009) 6:493&#x2013;5. doi:&#xa0;10.1038/nmeth.1342</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1342</ArticleId><ArticleId IdType="pmc">PMC3555078</ArticleId><ArticleId IdType="pubmed">19525957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc (2013) 8:2281&#x2013;308. doi:&#xa0;10.1038/nprot.2013.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.143</ArticleId><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita H, Yasuda T, Nakajima T, Hosomi O, Nakashima Y, Kishi K. Mouse deoxyribonuclease I (DNase i): Biochemical and immunological characterization, cDNA structure and tissue distribution. Biochem Mol Biol Int (1997) 42:65&#x2013;75. doi:&#xa0;10.1080/15216549700202441</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15216549700202441</ArticleId><ArticleId IdType="pubmed">9192086</ArticleId></ArticleIdList></Reference><Reference><Citation>Domeier PP, Schell SL, Rahman ZS. Spontaneous germinal centers and autoimmunity. Autoimmunity (2017) 50:4&#x2013;18. doi:&#xa0;10.1080/08916934.2017.1280671</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2017.1280671</ArticleId><ArticleId IdType="pmc">PMC5669068</ArticleId><ArticleId IdType="pubmed">28166685</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B. Plasma cell differentiation pathways in systemic lupus erythematosus. Front Immunol (2018) 9:427. doi:&#xa0;10.3389/fimmu.2018.00427</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00427</ArticleId><ArticleId IdType="pmc">PMC5845388</ArticleId><ArticleId IdType="pubmed">29556239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Sheng Y, Zhang X. Genetic susceptibility to SLE: Recent progress from GWAS. J Autoimmun (2013) 41:25&#x2013;33. doi:&#xa0;10.1016/j.jaut.2013.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.01.008</ArticleId><ArticleId IdType="pubmed">23395425</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder K, Herrmann M, Winkler TH. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity (2013) 46:121&#x2013;7. doi:&#xa0;10.3109/08916934.2012.748751</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2012.748751</ArticleId><ArticleId IdType="pubmed">23181829</ArticleId></ArticleIdList></Reference><Reference><Citation>Napirei M, Wulf S, Eulitz D, Mannherz HG, Kloeckl T. Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3). Biochem J (2005) 389:355&#x2013;64. doi:&#xa0;10.1042/BJ20042124</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20042124</ArticleId><ArticleId IdType="pmc">PMC1175112</ArticleId><ArticleId IdType="pubmed">15796714</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis (2008) 15:222&#x2013;34. doi:&#xa0;10.1053/j.ackd.2008.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2008.04.003</ArticleId><ArticleId IdType="pmc">PMC3287955</ArticleId><ArticleId IdType="pubmed">18565474</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>